Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18702965 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin;   Drug: Simvastatin

Study has passed its completion date and status has not been verified in more than two years.